<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Peregrine Pharmaceuticals Inc. | Company News & Executive Profiles - PPHM | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Peregrine Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="22" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Peregrine: Continuing to Accumulate on Any Dips]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F167557-peregrine-continuing-to-accumulate-on-any-dips%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  PPHM: Shares of Peregrine traded with some strength on Monday after the company opened trading after having have conducted a 1:5 reverse split.The company also took the opportunity on Monday morning to announce that former Genentech Senior Executive Dr. Robert Garnick has joined Peregrine as the Head...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 20 Oct 2009 07:01:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[Continuing to Accumulate Peregrine Pharma at Current Levels]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F165526-continuing-to-accumulate-peregrine-pharma-at-current-levels%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  On Monday Peregrine Pharmaceuticals issued a press release announcing Positive Results From the company's Phase II Bavituximab Lung Cancer Trial. A full copy of the press release is here.  The PR had little, if any, influence on the stock price. I started accumulating shares of this...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 08 Oct 2009 07:29:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals Inc., F1Q10 (Qtr End 07/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-338842.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions.  Our first question comes from Richard Siracusa - Merrill Lynch. Richard Siracusa - Merrill Lynch Joe, on that Cotara data that was reported yesterday, with the 41-week overall survival; isn&#8217;t that likely to increase as time goes by and these patients continue to...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 03 Sep 2009 14:00:45 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">MER,PPHM</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals Inc., F1Q10 (Qtr End 07/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159902-peregrine-pharmaceuticals-inc-f1q10-qtr-end-07-31-09-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Peregrine Pharmaceuticals Inc. PPHM   F1Q10 Earnings Call   September 3, 2009 11:30 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 03 Sep 2009 03:00:45 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals, Inc. F4Q09 (Qtr End 04/30/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-320324.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions Your first question comes from Stephen Dunn &#8211; Jesup & Lamont.   Stephen Dunn &#8211; Jesup & Lamont Can you give us a little color or guidance of when we would expect to see data from the multitude of phase II trials? ...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 14 Jul 2009 14:12:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fever.html"><![CDATA[Fever]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals, Inc. F4Q09 (Qtr End 04/30/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F148787-peregrine-pharmaceuticals-inc-f4q09-qtr-end-04-30-09-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Peregrine Pharmaceuticals Inc. PPHM   F4Q09 Earnings Call   July 14, 2009 11:30 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 14 Jul 2009 03:12:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals F2Q09 (Qtr End 10/31//08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-255000.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions Your first question comes from Ren Benjamin - Rodman.  Ren Benjamin &#8211; Rodman  A couple of questions; unfortunately I can make it one question, but it will be broken up into multiple parts, so however they want to take it. What...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 10 Dec 2008 10:13:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/quarter.html"><![CDATA[Quarter]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[OC Drug Makers Disagree with E&Y Financial Survey]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5293/is_20081208/ai_n31169617]]></link>
		<description><![CDATA[AMO Investor Resigns Other Board Position; Irvine Co. Unveils Genetic Test for Baldness   Even in this economy, larger drug makers are planning to spend money on research and development, according to a survey by Ernst & Young LLP. But many local companies aren't jumping on that bandwagon. Ernst...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 08 Dec 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/allergan+inc..html"><![CDATA[Allergan Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cargill+inc..html"><![CDATA[Cargill Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ista+pharmaceuticals+inc..html"><![CDATA[Ista Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISTA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">AGN,ISTA,PPHM,SPPI</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals, Inc. F1Q09 (Qtr End 07/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223437.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator instructions Our first question comes from Kevin Burdick [ph], a private investor. Kevin Burdick  Yes, gentlemen can you hear me? Steve King  Hey, good morning Kevin. How you doing? Kevin Burdick  Hey, the market cap for the company is roughly $74...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 09 Sep 2008 12:24:16 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
	<item>
		<title><![CDATA[Peregrine Pharmaceuticals, Inc. F4Q08 (Yr End 04/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-225939.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from Ren Benjamin - Rodman & Renshaw.  Ren Benjamin &#8211; Rodman & Renshaw You mentioned, having a plan ready for discussion at the hearing. You mentioned one particular item, the reverse split you try to address and stay on the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 14 Jul 2008 13:04:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/peregrine+pharmaceuticals+inc..html"><![CDATA[Peregrine Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PPHM</category>
		<category domain="tickers">PPHM</category>
	</item>
</channel>
</rss>
